2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (4353):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-42663
    1-(3,3-Dimethyl-6-nitroindolin-1-yl)ethanone
    1-(3,3-Dimethyl-6-nitroindolin-1-yl)ethanone is a drug intermediate for synthesis of various active compounds.
    1-(3,3-Dimethyl-6-nitroindolin-1-yl)ethanone
  • HY-20821
    Uradil impurity 1
    		99.81%
    Uradil impurity 1 is an impurity of Uradil.
    Uradil impurity 1
  • HY-32694
    1-(Piperidin-4-yl)-1H-imidazo[4,5-b]pyridin-2(3H)-one Hydrochloride
    		98.54%
    1-(Piperidin-4-yl)-1H-imidazo[4,5-b]pyridin-2(3H)-one Hydrochloride is a drug intermediate for synthesis of various active compounds.
    1-(Piperidin-4-yl)-1H-imidazo[4,5-b]pyridin-2(3H)-one Hydrochloride
  • HY-W002356
    2-Pyridinecarbothioamide
    		99.94%
    2-Pyridinecarbothioamide is a building block, that can be used for synthesis of Zn2+ responsive fluorescent probe.
    2-Pyridinecarbothioamide
  • HY-135197
    L-Iduronic acid sodium salt
    		99.0%
    L-Iduronic acid sodium salt is an important monosaccharide component of glycosaminoglycans (GAGs) such as Heparin, Heparan sulfate and Dermatan sulfate.
    L-Iduronic acid sodium salt
  • HY-W101650
    Propofol impurity 1
    		98.03%
    Propofol impurity 1 is an impurity of Propofol (HY-B0649).
    Propofol impurity 1
  • HY-Z0453
    Methyl 2-methoxybenzoate
    		99.79%
    Methyl 2-methoxybenzoate is a drug impurity.
    Methyl 2-methoxybenzoate
  • HY-W014347
    Methyl 3-methoxy-4-nitrobenzoate
    		99.48%
    Methyl 3-methoxy-4-nitrobenzoate is a drug intermediate for synthesis of various active compounds.
    Methyl 3-methoxy-4-nitrobenzoate
  • HY-W554832
    1-(4-Bromophenyl)-1,3-dihydro-2h-imidazol-2-one
    1-(4-Bromophenyl)-1,3-dihydro-2h-imidazol-2-one is a drug intermediate for synthesis of various active compounds.
    1-(4-Bromophenyl)-1,3-dihydro-2h-imidazol-2-one
  • HY-Z4752
    Nintedanib impurity 3
    		99.55%
    Nintedanib impurity 3 is an impurity of Nintedanib (HY-50904).
    Nintedanib impurity 3
  • HY-W001968
    3-Thiophenecarboxaldehyde
    3-Thiophenecarboxaldehyde is a thiophene derivative substrate for biocatalytic reduction to 3-thiophenemethanol, and can be processed by Pseudomonas putida S12 cells. 3-Thiophenecarboxaldehyde functions as an intermediate compound. 3-Thiophenecarboxaldehyde exhibits toxicity toward Pseudomonas putida S12 cells at elevated concentrations, reducing specific growth rate and final biomass yield.
    3-Thiophenecarboxaldehyde
  • HY-W702781
    1,3-Distearin
    		99.71%
    1,3-Distearin (1,3-Distearoyl glycerol) is an intermediate for synthesizing non-steroidal anti-inflammatory agents, and can be used in the synthesis of Ibuprofen (HY-78131), Naproxen (HY-15030), Diclofenac (HY-15036), and other non-steroidal anti-inflammatory agents.
    1,3-Distearin
  • HY-Z0422
    3,5-Dimethylbenzonitrile
    		99.90%
    3,5-Dimethylbenzonitrile is a drug impurity.
    3,5-Dimethylbenzonitrile
  • HY-W097355
    (R)-2-Amino-3-phenylpropanamide
    		99.23%
    (R)-2-Amino-3-phenylpropanamide (D-Phenylalanine amide) is a non-natural D-α-amino acid derivative and chiral amino acid amide. (R)-2-Amino-3-phenylpropanamide can be converted into D-Phenylalanine (HY-Y0079), which is applicable to the construction of all-D antimicrobial peptides and the synthesis of anti-HIV reagents. (R)-2-Amino-3-phenylpropanamide serves as a reagent for synthesizing benzoxaborole derivative 6, a dual covalent binder of Pseudomonas aeruginosa PBP3. (R)-2-Amino-3-phenylpropanamide is used in colon cancer-related research.
    (R)-2-Amino-3-phenylpropanamide
  • HY-I0496
    Linagliptin impurity 34
    		99.81%
    Linagliptin impurity 34 is an impurity of Linagliptin (HY-10284).
    Linagliptin impurity 34
  • HY-Z1112
    Favipiravir impurity 5
    		98.74%
    Favipiravir impurity 5 is an impurity of Favipiravir (HY-14768).
    Favipiravir impurity 5
  • HY-23326
    (2S,5S)-Methyl 5-phenylpyrrolidine-2-carboxylate hydrochloride
    		98.50%
    (2S,5S)-Methyl 5-phenylpyrrolidine-2-carboxylate hydrochloride is a drug intermediate for synthesis of various active compounds.
    (2S,5S)-Methyl 5-phenylpyrrolidine-2-carboxylate hydrochloride
  • HY-Z8691
    Timolol impurity 1
    		98.75%
    Timolol impurity 1 is an impurity of Timolol (HY-17494).
    Timolol impurity 1
  • HY-20195A
    3-(4-Bromo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
    3-(4-Bromo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile is a drug intermediate for synthesis of various active compounds.
    3-(4-Bromo-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
  • HY-I0777
    1,2-Diacetylhydrazine
    		99.0%
    1,2-Diacetylhydrazine (N,N'-Diacetylhydrazine) is a drug impurity.
    1,2-Diacetylhydrazine